Xenon Pharmaceuticals Inc. - COM (XENE)

Historical Portfolio Holders from Q4 2014 to Q3 2024

All holders as of June 30, 2024
Q2 2024
Type / Class
Equity / COM
Shares, excl. options Q2 2024
74.1M
Holdings value Q2 2024
$2.89B
Value change Q2 2024
+$26.1M
Grand Portfolio weight change Q2 2024
+0%
Number of holders
209
Number of buys Q2 2024
96
Number of sells Q2 2024
-98
Average buys Q2 2024 %
+0.001%
Average sells Q2 2024 %
-0.002%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q3 30.4K $1.2M -$662K $39.39 2
2024 Q2 74.1M $2.89B +$26.1M $38.99 210
2024 Q1 73.4M $3.16B +$66.4M $43.05 219
2023 Q4 71.4M $3.29B +$474M $46.06 208
2023 Q3 60.8M $2.08B +$8.31M $34.16 180
2023 Q2 61.3M $2.36B +$10.3M $38.50 172
2023 Q1 61.1M $2.18B +$24.6M $35.79 163
2022 Q4 60.4M $2.38B +$38.7M $39.43 157
2022 Q3 57.9M $2.09B +$37.1M $36.10 150
2022 Q2 57M $1.73B +$237M $30.42 149
2022 Q1 49M $1.5B +$45M $30.57 129
2021 Q4 47.7M $1.49B +$452M $31.24 130
2021 Q3 34.1M $521M +$348K $15.28 117
2021 Q2 33.3M $620M +$2.57M $18.62 99
2021 Q1 33M $590M +$88.8M $17.90 89
2020 Q4 28M $431M -$1.91M $15.38 80
2020 Q3 27.9M $309M -$547K $11.07 79
2020 Q2 28M $351M +$8.43M $12.54 79
2020 Q1 27.7M $314M +$101M $11.34 69
2019 Q4 18.7M $245M +$22.4M $13.11 67
2019 Q3 16.1M $145M -$14.7M $9.01 53
2019 Q2 17.6M $173M -$1.95M $9.86 59
2019 Q1 17.7M $180M +$3M $10.16 61
2018 Q4 17.5M $110M -$24.4M $6.31 56
2018 Q3 17.7M $234M +$115M $13.20 59
2018 Q2 9.04M $83.2M +$29.1M $9.20 41
2018 Q1 6.35M $31.1M -$13.8M $4.90 35
2017 Q4 9.16M $25.9M -$498K $2.83 30
2017 Q3 9.32M $27.5M -$1.98M $2.95 30
2017 Q2 9.95M $31.3M -$1.13M $3.15 38
2017 Q1 10.1M $40.3M -$3.17M $4.00 36
2016 Q4 10.5M $80.8M +$2.07M $7.70 31
2016 Q3 9.93M $80.2M +$36.8M $8.10 30
2016 Q2 5.36M $31.7M -$2.51M $5.90 19
2016 Q1 5.71M $39.9M -$1.43M $6.99 25
2015 Q4 5.76M $46.3M +$2.27M $8.04 24
2015 Q3 5.48M $45.2M +$5.12M $8.26 25
2015 Q2 4.81M $55.4M +$3.17M $11.53 25
2015 Q1 4.45M $75.2M +$2.92M $16.86 23
2014 Q4 4.28M $83.1M +$76.7M $19.75 16